Literature DB >> 21655157

Pan-Canadian initiatives in colorectal cancer screening: adopting knowledge translation tools to accelerate uptake and impact.

H E Bryant1, S V Fekete, D H Major.   

Abstract

BACKGROUND: Despite the positive conclusions of several randomized controlled trials and the publication of national recommendations on colorectal cancer (crc) screening, uptake remained low. The inauguration of the National Colorectal Cancer Screening Network in 2007, the same year that the first screening program was announced in Canada, provided an opportunity for integrated knowledge translation to accelerate the processes of program implementation and screening uptake. AIM: Two primary aims were identified. The first focused on means to monitor the effects of various implementation plans in delivering high-quality population-based crc screening. The second focused on identifying and addressing knowledge gaps that may impair screening participation.
METHOD: The methods used are described in the context of the knowledge-to-action cycle and demonstrate that the initiative itself dictates the point in the cycle at which to start.
RESULTS: The identified need to monitor various implementation plans resulted in the shared development of a quality determinants document. All programs committed to designing data collection so that core components could be measured and compared; 6 operating programs have conducted the first data collection, which will allow for monitoring and for new knowledge creation as the process develops further. The knowledge gap identification project started with new knowledge creation, which identified a higher-than-expected willingness of Canadians to discuss crc screening with physicians, but a low level of understanding of screening as a wellness-related behaviour. Knowledge translation interventions have been developed with the stakeholders to address those gaps, and ongoing surveys to be carried out later in 2011 will help to gauge progress in the understanding and acceptance of crc screening by the population.
CONCLUSIONS: A national network that engaged all programs, policymakers, experts, and lay representatives successfully used knowledge translation principles to enhance the trajectory of crc screening in Canada.

Entities:  

Keywords:  Knowledge translation; colorectal cancer; screening; screening programs

Year:  2011        PMID: 21655157      PMCID: PMC3108864          DOI: 10.3747/co.v18i3.889

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  20 in total

1.  How to translate health research knowledge into effective healthcare action.

Authors:  Ian D Graham; Jacqueline Tetroe
Journal:  Healthc Q       Date:  2007

Review 2.  Defining knowledge translation.

Authors:  Sharon E Straus; Jacqueline Tetroe; Ian Graham
Journal:  CMAJ       Date:  2009-07-20       Impact factor: 8.262

Review 3.  Diffusion theory and knowledge dissemination, utilization, and integration in public health.

Authors:  Lawrence W Green; Judith M Ottoson; César García; Robert A Hiatt
Journal:  Annu Rev Public Health       Date:  2009       Impact factor: 21.981

4.  Perception versus reality: overcoming barriers to colorectal cancer screening.

Authors:  Heather Bryant; S Elizabeth McGregor
Journal:  Can Fam Physician       Date:  2008-04       Impact factor: 3.275

Review 5.  Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper.

Authors:  Michael J Duffy; Leo G M van Rossum; Sietze T van Turenhout; Outi Malminiemi; Catherine Sturgeon; Rolf Lamerz; Andrea Nicolini; Caj Haglund; Lubos Holubec; Callum G Fraser; Stephen P Halloran
Journal:  Int J Cancer       Date:  2011-01-01       Impact factor: 7.396

6.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

7.  Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Authors:  O Kronborg; C Fenger; J Olsen; O D Jørgensen; O Søndergaard
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

8.  Follow-up after screening for colorectal neoplasms with fecal occult blood testing in a controlled trial.

Authors:  J Kewenter; H Brevinge; B Engarås; E Haglind; C Ahrén
Journal:  Dis Colon Rectum       Date:  1994-02       Impact factor: 4.585

9.  Colorectal cancer screening: practices and opinions of primary care physicians.

Authors:  S Elizabeth McGregor; Robert J Hilsden; Alison Murray; Heather E Bryant
Journal:  Prev Med       Date:  2004-08       Impact factor: 4.018

10.  Colorectal cancer testing in Canada--2008.

Authors:  Kathryn Wilkins; Margot Shields
Journal:  Health Rep       Date:  2009-09       Impact factor: 4.796

View more
  5 in total

1.  Improving cancer control in Canada through knowledge translation: from in-the-field projects to policy initiatives in a new standing section in Current Oncology.

Authors:  M A O'Brien; E Grunfeld
Journal:  Curr Oncol       Date:  2012-04       Impact factor: 3.677

2.  A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival.

Authors:  C Graham; C Orr; C S Bricks; W M Hopman; N Hammad; R Ramjeesingh
Journal:  Curr Oncol       Date:  2016-12-21       Impact factor: 3.677

3.  Nutrition and Cancer Prevention: Why is the Evidence Lost in Translation?

Authors:  Katie M Di Sebastiano; Gayathri Murthy; Kristin L Campbell; Sophie Desroches; Rachel A Murphy
Journal:  Adv Nutr       Date:  2019-05-01       Impact factor: 8.701

Review 4.  Integrated Knowledge Translation with Public Health Policy Makers: A Scoping Review.

Authors:  Logan M Lawrence; Andrea Bishop; Janet Curran
Journal:  Healthc Policy       Date:  2019-02

5.  Patterns and predictors of adherence to colorectal cancer screening recommendations in Alberta's Tomorrow Project participants stratified by risk.

Authors:  Nathan M Solbak; Jian-Yi Xu; Jennifer E Vena; Ala Al Rajabi; Sanaz Vaseghi; Heather K Whelan; S Elizabeth McGregor
Journal:  BMC Public Health       Date:  2018-01-25       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.